Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters
Michaela A. Ihle(University of Cologne), Sabine Merkelbach‐Bruse(University Hospital Cologne), Daniela Vorholt(Johnson & Johnson (Germany)), Matthias Evert(University of Regensburg), Maja Grassow-Narlik, Anja Haak(University Hospital in Halle), Thomas Mairinger(Helios Klinikum Emil von Behring), Anna Streubel(Helios Klinikum Emil von Behring), Daniela Aust(Technische Universität Dresden), Martin Werner(University of Freiburg), Anne M. Schultheis(University of Freiburg), Wolfgang Dietmaier(University of Regensburg), Carina Heydt(University of Cologne), Frank Breitenbücher(Johnson & Johnson (Germany)), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Markus Eszlinger(University Hospital in Halle), Silke Laßmann(University of Freiburg), Sylvia Herold(University Hospital Carl Gustav Carus), Florian Haller(Universitätsklinikum Erlangen)
Cited by 4
Related Papers
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
The Characteristics of 50 Hospitalized COVID-19 Patients With and Without ARDS
|Deutsches Ärzteblatt international|2020|258
The MicroRNA Profile of Prostate Carcinoma Obtained by Deep Sequencing
|Molecular Cancer Research|2010|227